MassMutual Private Wealth & Trust’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio BIB Stock Details BIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-79	Closed	-$4.38K	–	753
2019 Q1	$4.38K	Hold	79	–	–	﹤0.01%	700
2018 Q4	$3.33K	Sell	79 -79	-50%	-$4.12K	﹤0.01%	738
2018 Q3	$11K	Hold	158	–	–	﹤0.01%	590
2018 Q2	$9.04K	Hold	158	–	–	﹤0.01%	628
2018 Q1	$8.7K	Hold	158	–	–	﹤0.01%	619
2017 Q4	$8.86K	Buy	158 +93	+143%	+$5.25K	﹤0.01%	621
2017 Q3	$3.98K	Buy	+65	New	+$3.7K	﹤0.01%	863

Other funds holding BIB

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

CIC

Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SBIA

Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return

BRC

Bell Rock Capital Rehoboth Beach, Delaware $81M AUM 9.85% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

MassMutual Private Wealth & Trust's BIB Position: Q2 2019 in Review

MassMutual Private Wealth & Trust sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q2 2019, closing a stake of 79 shares — an estimated $4.38K sold.

MassMutual Private Wealth & Trust first reported a position in BIB in Q3 2017 and held it in 7 quarters. The position peaked at $11K in Q3 2018. 34 funds tracked by Wall St. Rank hold BIB as of Q2 2019.

MassMutual Private Wealth & Trust reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q2 2019 after selling out during the quarter.
MassMutual Private Wealth & Trust sold 79 ProShares Ultra NASDAQ Biotechnology shares in Q2 2019, an estimated $4.38K.
MassMutual Private Wealth & Trust first reported a position in ProShares Ultra NASDAQ Biotechnology in Q3 2017 and held it in 7 quarters.
MassMutual Private Wealth & Trust's ProShares Ultra NASDAQ Biotechnology position peaked at $11K in Q3 2018.
34 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2019.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2019, filed 14 Aug 2019.